Trial Profile
Antibody response in healthy adolsescent females recieved two or three quadrivalent human papillomavirus vaccine at standard or prolonged intervals
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 12 Feb 2018
Price :
$35
*
At a glance
- Drugs Human papillomavirus vaccine (Primary)
- Indications Human polyomavirus infections
- Focus Therapeutic Use
- 12 Feb 2018 New trial record
- 03 Jan 2018 Results published in the Vaccine